LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

Search

Odonate Therapeutics Inc

Ouvert

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Odonate Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

26 mars 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 mars 2026, 23:36 UTC

Market Talk
Principaux Événements d'Actualité

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 mars 2026, 23:35 UTC

Acquisitions, Fusions, Rachats

Pernod Ricard: Confirms Discussions With Brown-Forman

26 mars 2026, 23:29 UTC

Résultats

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 mars 2026, 23:28 UTC

Résultats

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 mars 2026, 23:28 UTC

Résultats

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 mars 2026, 23:28 UTC

Résultats

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 mars 2026, 23:27 UTC

Résultats

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 mars 2026, 23:27 UTC

Résultats

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 mars 2026, 23:08 UTC

Market Talk

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Pernod in Deal Talks With Brown-Forman -- WSJ

26 mars 2026, 22:41 UTC

Acquisitions, Fusions, Rachats

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 mars 2026, 22:41 UTC

Acquisitions, Fusions, Rachats

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 mars 2026, 22:26 UTC

Résultats

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 mars 2026, 22:26 UTC

Résultats

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 mars 2026, 22:26 UTC

Résultats

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 mars 2026, 22:08 UTC

Résultats

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 mars 2026, 22:08 UTC

Résultats

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 mars 2026, 22:08 UTC

Résultats

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 mars 2026, 22:07 UTC

Market Talk
Principaux Événements d'Actualité

Global Energy Roundup: Market Talk

26 mars 2026, 22:07 UTC

Market Talk
Principaux Événements d'Actualité

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 mars 2026, 22:00 UTC

Résultats

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 mars 2026, 22:00 UTC

Résultats

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 mars 2026, 22:00 UTC

Résultats

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 mars 2026, 21:39 UTC

Acquisitions, Fusions, Rachats

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 mars 2026, 21:38 UTC

Acquisitions, Fusions, Rachats

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Comparaison

Variation de prix

Odonate Therapeutics Inc prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat